Access the full text.
Sign up today, get DeepDyve free for 14 days.
A. Gomtsyan, C. Faltynek (2010)
Vanilloid receptor TRPV1 in drug discovery
M. Wallace, M. Pappagallo (2011)
Qutenza®: a capsaicin 8% patch for the management of postherpetic neuralgiaExpert Review of Neurotherapeutics, 11
N. Finnerup, S. Sindrup, T. Jensen (2010)
The evidence for pharmacological treatment of neuropathic painPAIN, 150
J. England, T. Wagner, K. Kern, A. Roth-Daniek, Angela Sell (2011)
The capsaicin 8% patch for peripheral neuropathic pain.British journal of nursing, 20 15
R. Baron, A. Binder, G. Wasner (2010)
Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatmentThe Lancet Neurology, 9
G. Irving, M. Backonja, E. Dunteman, E. Blonsky, G. Vanhove, Shiao-ping Lu, J. Tobias (2011)
A multicenter, randomized, double-blind, controlled study of NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia.Pain medicine, 12 1
G. Petersen, N. Finnerup, K. Nørskov, K. Grosen, H. Pilegaard, F. Benedetti, D. Price, T. Jensen, L. Vase (2012)
Placebo manipulations reduce hyperalgesia in neuropathic painPAIN, 153
R. Rolke, W. Magerl, K. Campbell, C. Schalber, S. Caspari, F. Birklein, R. Treede (2006)
Quantitative sensory testing: a comprehensive protocol for clinical trialsEuropean Journal of Pain, 10
P. Anand, K. Bley (2011)
Topical capsaicin for pain management: therapeutic potential and mechanisms of action of the new high-concentration capsaicin 8% patchBJA: British Journal of Anaesthesia, 107
A. Malmberg, A. Mizisin, N. Calcutt, T. Stein, W. Robbins, K. Bley (2004)
Reduced heat sensitivity and epidermal nerve fiber immunostaining following single applications of a high-concentration capsaicin patchPain, 111
M. Rowbotham, H. Fields (1996)
The relationship of pain, allodynia and thermal sensation in post-herpetic neuralgia.Brain : a journal of neurology, 119 ( Pt 2)
R. Dworkin, Alec O’Connor, J. Audette, R. Baron, G. Gourlay, M. Haanpää, Joel Kent, E. Krane, A. Lebel, R. Levy, S. Mackey, J. Mayer, C. Miaskowski, S. Raja, A. Rice, K. Schmader, B. Stacey, S. Stanos, R. Treede, D. Turk, G. Walco, C. Wells (2010)
Recommendations for the pharmacological management of neuropathic pain: an overview and literature update.Mayo Clinic proceedings, 85 3 Suppl
R. Routledge (1994)
Practicing safe statistics with the mid-p*Canadian Journal of Statistics-revue Canadienne De Statistique, 22
B. Gustorff, David Hauer, J. Thaler, Astrid Seis, J. Draxler (2011)
Antihyperalgesic efficacy of 5% lidocaine medicated plaster in capsaicin and sunburn pain models – two randomized, double-blinded, placebo-controlled crossover trials in healthy volunteersExpert Opinion on Pharmacotherapy, 12
R. Rolke, R. Baron, C. Maier, T. Tölle, R. Treede, A. Beyer, A. Binder, N. Birbaumer, F. Birklein, I. Bötefür, S. Braune, Herta Flor, V. Huge, R. Klug, G. Landwehrmeyer, W. Magerl, C. Maihöfner, C. Rolko, C. Schaub, A. Scherens, T. Sprenger, M. Valet, B. Wasserka (2006)
Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): Standardized protocol and reference valuesPAIN, 123
W. Kennedy, G. Vanhove, Shiao-ping Lu, J. Tobias, K. Bley, D. Walk, G. Wendelschafer‐Crabb, D. Simone, M. Selim (2010)
A randomized, controlled, open-label study of the long-term effects of NGX-4010, a high-concentration capsaicin patch, on epidermal nerve fiber density and sensory function in healthy volunteers.The journal of pain : official journal of the American Pain Society, 11 6
Vania Apkarian, J. Hashmi, M. Baliki (2011)
Pain and the brain: Specificity and plasticity of the brain in clinical chronic painPAIN, 152
D. Simpson, Stephen Brown, J. Tobias (2008)
Controlled trial of high-concentration capsaicin patch for treatment of painful HIV neuropathyNeurology, 70
P. McCormack (2010)
Capsaicin Dermal PatchDrugs, 70
K. Bley (2010)
TRPV1 Agonist Approaches for Pain Management
M. Backonja, D. Walk, R. Edwards, N. Sehgal, T. Moeller‐Bertram, A. Wasan, G. Irving, C. Argoff, M. Wallace (2009)
Quantitative Sensory Testing in Measurement of Neuropathic Pain Phenomena and Other Sensory AbnormalitiesThe Clinical Journal of Pain, 25
M. Backonja, Mark Wallace, E Blonsky, Barry Cutler, P. Malan, R. Rauck, J. Tobias (2008)
NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind studyThe Lancet Neurology, 7
M. Backonja, T. Malan, G. Vanhove, J. Tobias (2010)
NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomized, double-blind, controlled study with an open-label extension.Pain medicine, 11 4
C. Geber, A. Scherens, Doreen Pfau, N. Nestler, M. Zenz, Thomas Tölle, R. Baron, R. Treede, C. Maier (2009)
Zertifizierungsrichtlinien für QST-LaboreDer Schmerz, 23
AbstractBackground and aimsPeripheral neuropathic pain (PNeP) is a chronic and disabling condition for which no predictors of response to treatment have yet been identified. Clinical studies show that while many patients with PNeP respond positively to treatment with the capsaicin 8% patch, others do not. This study used quantitative sensory testing (QST) to determine whether any patient characteristics can predict response to treatment with the capsaicin 8% patch.MethodsThis was a prospective, non-placebo-controlled, observational study. Patients used the Visual Analogue Scale (VAS) to assess their pain at baseline and then on Days 1, 7–10 (from here referred to as Day 7/10), 28 and 84 following treatment with the capsaicin 8% patch. QST was undertaken at the same timepoints on the painful area at the region of maximum PNeP and on a contralateral, control area. In addition, the size of the painful area was assessed at baseline and Days 7/10, 28 and 84.ResultsA total of 57 patients were treated. Among 54 evaluable patients, 19 (35.2%) achieved a ≥30% reduction in VAS pain score at Day 7/10 post-treatment compared with baseline — these were defined as ‘responders’. Analysis of the QST data showed that the PNeP area in responders, but not in non-responders, had a significantly lower pressure pain threshold compared with the control area at baseline (median 320 kPa vs. 480 kPa, respectively; p = .004). Furthermore, non-responders had approximately three times greater degree of allodynia at baseline compared with responders across tests using brush, cotton wool and Q-tip. These differences were significant for tests using brush and cotton wool (p = .024 and p = .046, respectively) and approached significance in the test using Q-tip (p = .066). Following treatment with the capsaicin 8% patch, responders showed a trend towards a reduction in warm perception and also appeared to show normalization of the pinprick hyperalgesia at some stimulus levels. Responders to therapy had significantly greater reductions than non-responders in the size of the painful area at Day 28 (p = .011) and Day 84 (p = .005) following treatment. However, both responders and non-responders had meaningful reductions in the size of the painful area compared with baseline values.ConclusionsThis study suggests that differences can be identified in the sensory profiles of patients with PNeP who respond to the capsaicin 8% patch and those who do not, specifically pressure pain threshold and degree of allodynia. Notably, both responders and non-responders experienced meaningful reductions in the size of the painful area following treatment.ImplicationsThe findings warrant further investigation in a larger number of patients and in prospective trials.
Scandinavian Journal of Pain – de Gruyter
Published: Jul 1, 2013
Keywords: Peripheral neuropathic pain; Quantitative sensory testing; Capsaicin 8% patch; Sensory profile
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.